DNA Modifying Enzymes Market Report 2025: Size, Trends, and Growth Insights for Global Expansion

February 14, 2025 06:35 PM AEDT | By EIN Presswire
 DNA Modifying Enzymes Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, February 14, 2025 /EINPresswire.com/ -- The DNA Modifying Enzymes Global Market is poised for significant growth, with projections anticipating a rise from $4.34 billion in 2024 to $5.08 billion in 2025. This presents a compound annual growth rate CAGR of 16.9%. The robust growth during the historic period can be attributed to the increasing funding for biotechnology, rising demand in molecular biology, bio-fuels, bio-detergents, and paper manufacturing processes, along with a rising frequency of genetic illnesses. In addition, the increasing demand for ligases in applications and DNA modifying enzymes is a contributory factor.

What does the next decade hold for the DNA Modifying Enzymes Global Market?
The market is predicted to witness rapid growth in the next few years. Forecast to grow to $9.37 billion in 2029 at a compound annual growth rate CAGR of 16.6%, the growth during this period is expected to be a result of an increase in the prevalence of infectious diseases, birth rate, and genetic disorders. Additionally, the growing demand for polymerases, high-quality healthcare treatments, rising need for customized medicine, and significant advancements in genetic research, genomics, biotechnology, and other technological innovations are all expected to contribute to market growth.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20545&type=smp

What's driving the growth of the DNA modifying enzymes market in the years to come?
The rising frequency of genetic illnesses is slated to drive the market growth. Genetic illnesses, also known as genetic disorders, are health problems that stem from abnormalities in an individual's genetic material. Factors like genetic inheritance, increased awareness and diagnosis, and environmental factors contribute to the increasing frequency of these genetic diseases. DNA modifying enzymes such as DNA polymerase and DNA ligase play a crucial role in genetic testing, helping identify the genetic mutations that cause disorders. For instance, by March 2024, over 6,000 genetic conditions have been identified, with new ones being discovered daily. As per the Gene People, a UK-based registered charity for people with genetic disorders, 1 in 25 children in the UK are affected by these genetic conditions, resulting in over 2.4 million individuals living with them.

Who are the major players in this exciting and thriving market?
Some of the key industry players operating in the DNA modifying enzymes market include Merck & Co. Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., Promega Corporation, Aldevron LLC, Takara Bio Inc., New England Biolabs Inc., Diagenode SA, among others.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/dna-modifying-enzymes-global-market-report

Any groundbreaking innovations in the DNA modifying enzymes market from key industry players?
Many companies are focusing on developing advanced solutions, such as a two-step enzymatic conversion workflow, to stand out in the competition. This workflow permits specific detection of 5-hydroxymethylcytosine 5 hmC at single-base resolution, thereby reducing DNA damage. For instance, in February 2024, New England Biolabs, a U.S.-based life sciences company, launched the NEBNext Enzymatic 5hmC-seq Kit for enzyme-based 5hmC detection at single-base resolution. The introduction of this kit signifies a significant step forward in epigenetic research, particularly in the study of DNA modifications that play essential roles in gene regulation.

How is the DNA Modifying Enzymes Global Market segmented?
The report segments the market as follows:

1 By Type: Restriction Enzymes, Polymerases, Ligases, Nucleases, Methylases, Other Enzyme Types
2 By Applications: Genomics And Gene Editing, Molecular Biology Research, Diagnostics And Forensics, Biotechnology And Synthetic Biology, Diagnostics, Drug Discovery And Development
3 By End-User: Academics And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Forensic Laboratories, Hospitals And Clinics, Contract Research Organizations

Furthermore, the report breaks down these segments, offering valuable insights into Restriction Enzymes, Polymerases, Ligases, Nucleases, Methylases among other types of enzymes.

How is the DNA modifying enzymes market spread out geographically?
Among the different regions, North America held the largest market share in 2024. However, the DNA modifying enzymes market spans across several other regions as well, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:
Viral Vectors And Plasmid DNA Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
DNA Based Skin Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report
DNA And Gene Chip Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

About the Business Research Company
With over 15,000+ reports spanning 27 industries and covering 60+ geographies, The Business Research Company has established a reputation for providing comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, in-depth secondary research, and exclusive insights from industry leaders, you can get the information you need to stay ahead of the curve.

Contact us at:
The Business Research Company.
Americas: +1 3156230293
Asia: +44 2071930708
Europe: +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.